206 related articles for article (PubMed ID: 17416416)
1. The incidence and survival of Waldenström's Macroglobulinaemia in South East England.
Phekoo KJ; Jack RH; Davies E; Møller H; Schey SA;
Leuk Res; 2008 Jan; 32(1):55-9. PubMed ID: 17416416
[TBL] [Abstract][Full Text] [Related]
2. Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.
Groves FD; Travis LB; Devesa SS; Ries LA; Fraumeni JF
Cancer; 1998 Mar; 82(6):1078-81. PubMed ID: 9506352
[TBL] [Abstract][Full Text] [Related]
3. A 20-year retrospective study of tonsil cancer incidence and survival trends in South East England: 1987-2006.
Olaleye O; Moorthy R; Lyne O; Black M; Mitchell D; Wiseberg J
Clin Otolaryngol; 2011 Aug; 36(4):325-35. PubMed ID: 21696555
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the incidence and mortality of vulval cancer in women in South East England 1960-1999.
Somoye GO; Mocroft A; Olaitan A
Arch Gynecol Obstet; 2009 Feb; 279(2):113-7. PubMed ID: 18488239
[TBL] [Abstract][Full Text] [Related]
5. Trends in the incidence and survival of cancer in teenagers and young adults: regional analysis for South East England 1960-2002.
Croucher C; Whelan JS; Møller H; Davies EA
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):417-24. PubMed ID: 19375901
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001.
Sanjoaquin MA; Choodari-Oskooei B; Dolbear C; Putcha V; Sehgal A; Key TJ; Møller H
Eur J Cancer Prev; 2007 Feb; 16(1):10-6. PubMed ID: 17220699
[TBL] [Abstract][Full Text] [Related]
7. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
[TBL] [Abstract][Full Text] [Related]
8. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic Waldenstrom's macroglobulinemia.
Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
[TBL] [Abstract][Full Text] [Related]
10. Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003.
Iwanaga M; Chiang CJ; Soda M; Lai MS; Yang YW; Miyazaki Y; Matsuo K; Matsuda T; Sobue T
Int J Cancer; 2014 Jan; 134(1):174-80. PubMed ID: 23784625
[TBL] [Abstract][Full Text] [Related]
11. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
Ghobrial IM; Fonseca R; Gertz MA; Plevak MF; Larson DR; Therneau TM; Wolf RC; Hoffmann RJ; Lust JA; Witzig TE; Lacy MQ; Dispenzieri A; Vincent Rajkumar S; Zeldenrust SR; Greipp PR; Kyle RA
Br J Haematol; 2006 Apr; 133(2):158-64. PubMed ID: 16611306
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic spectrum of Waldenström's macroglobulinemia: a single center experience.
Sajid R; Siddiqui SH; Shaikh U; Adil S
Indian J Pathol Microbiol; 2010; 53(3):490-3. PubMed ID: 20699509
[TBL] [Abstract][Full Text] [Related]
14. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.
Phekoo KJ; Schey SA; Richards MA; Bevan DH; Bell S; Gillett D; Møller H;
Br J Haematol; 2004 Nov; 127(3):299-304. PubMed ID: 15491289
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
[TBL] [Abstract][Full Text] [Related]
16. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
17. Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors.
Owen RG; Barrans SL; Richards SJ; O'Connor SJ; Child JA; Parapia LA; Morgan GJ; Jack AS
Am J Clin Pathol; 2001 Sep; 116(3):420-8. PubMed ID: 11554171
[TBL] [Abstract][Full Text] [Related]
18. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in Waldenstrom's macroglobulinemia: description of the complications during the evolution-preliminary results on 101 patients.
Stalnikiewicz L; Carrotte-Lefebvre I; Detourmignies L; Rose C; Cazin B; Leblond V; Morel P
Semin Oncol; 2003 Apr; 30(2):216-9. PubMed ID: 12720139
[TBL] [Abstract][Full Text] [Related]
20. The incidence and epidemiology of plasma cell neoplasms.
Bergsagel D
Stem Cells; 1995 Aug; 13 Suppl 2():1-9. PubMed ID: 8520495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]